NVN Liquidation
Presence
Ligand Pharmaceuticals is one of the...
Ligand Pharmaceuticals is a company listed under the stock ticker LGND (US).
They are in:
- Pharmaceuticals67%
- Biotechnology33%
Executives
View the org chart displaying its 5 main executives
Most searched biographies at NVN Liquidation
- Scott Plesha, Chief Executive Officer
- John Gay, Chief Financial Officer
- Carri Geer, Senior Vice President and Chief Technology Officer
Popular executive movements at Ligand Pharmaceuticals
- Martine Zimmermann has joined the company as Director (posted on September 27 2023).
Create your alert
to follow the executive moves at NVN Liquidation.
Biotechnology
Ligand Pharmaceuticals has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by NVN Liquidation
- Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference | Novan, Inc.
- Novan to Participate in the Virtual Investor Roundtable Event | Novan, Inc.
- Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results | Novan, Inc.
- Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19 | Novan, Inc.
- Novan Announces Fireside Chat Hosted by Jonathan Aschoff, Ph.D. of ROTH Capital Partners | Novan, Inc.
- Novan to Report Third Quarter 2021 Financial Results on November 10, 2021 | Novan, Inc.
- Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum | Novan, Inc.
- Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206 - Novan, Inc.
- Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference - Novan, Inc.
- Novan Announces Strategic Priorities and Outlines Key Milestones - Novan, Inc.
- View more press releases Close
Social media about NVN Liquidation
- NVN Liquidation on Wikipedia, Google News & Yahoo Finance
- NVN Liquidation on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including John Gay 
Call NVN Liquidation at +1 919...
